Acorah Software Products - Accounts Production 19.3.600 true true 30 April 2025 1 May 2024 false true No description of principal activity 1 May 2025 30 April 2026 30 April 2026 14314227 Dr. Sarah Temple iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14314227 2025-04-30 14314227 2026-04-30 14314227 2025-05-01 2026-04-30 14314227 frs-core:CurrentFinancialInstruments 2026-04-30 14314227 frs-bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 14314227 frs-bus:FilletedAccounts 2025-05-01 2026-04-30 14314227 frs-bus:Micro-entities 2025-05-01 2026-04-30 14314227 frs-bus:EntityHasNeverTraded 2025-05-01 2026-04-30 14314227 frs-bus:AuditExempt-NoAccountantsReport 2025-05-01 2026-04-30 14314227 frs-bus:Director1 2025-05-01 2026-04-30 14314227 2024-04-30 14314227 2025-04-30 14314227 2024-05-01 2025-04-30 14314227 frs-core:CurrentFinancialInstruments 2025-04-30
Registered number: 14314227
Fritchley Clinical Development Ltd
Unaudited Financial Statements
For The Year Ended 30 April 2026
TaxAssist Accountants
Balance Sheet
Registered number: 14314227
2026 2025
£ £
Fixed assets 933 933
Current assets 130,840 130,840
Creditors: Amounts Falling Due Within One Year (17,657 ) (17,657 )
NET CURRENT ASSETS 113,183 113,183
TOTAL ASSETS LESS CURRENT LIABILITIES 114,116 114,116
Accruals and deferred income (780 ) (780 )
NET ASSETS 113,336 113,336
CAPITAL AND RESERVES 113,336 113,336

Notes

1. General Information
Fritchley Clinical Development Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14314227 . The registered office is 15 Rosecomb, Royston, Herts, SG8 9FL.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
Page 0
Page 1
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr. Sarah Temple
Director
14 September 2026